Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of IL-23 Inhibitors in Patients With Active Crohn's Disease: A Prospective, Multicenter, Observational Study

NCT07545317 is registered in ClinicalTrials.gov with Sixth Affiliated Hospital, Sun Yat-sen University as lead sponsor.

NCT NCT07545317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07545317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of IL-23 Inhibitors in Patients With Active Crohn's Disease: A Prospective, Multicenter, Observational Study
Lead sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Observational
Overall status
Recruiting
Start date
April 16, 2026
Completion date
August 31, 2028
Enrollment
665 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease